The Arming of Natural Killer Cells With Fc‐Engineered Monoclonal Antibodies Confers Specificity Against Tumor B Cells
- DOI
- 10.1002/mco2.70242
- Published
- 2025-07
- Container
- MedComm
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/mco2.70242,
title = {The Arming of Natural Killer Cells With Fc‐Engineered Monoclonal Antibodies Confers Specificity Against Tumor B Cells},
author = {Michaël Constantinides and Loïs Coënon and Paolo Falvo and Caroline Multrier and Davide Lombardi and Francesco Bertolini and Pierre Martineau and Bruno Robert and Guillaume Cartron and Martin Villalba},
year = {2025},
journal = {MedComm},
doi = {10.1002/mco2.70242},
url = {https://doi.org/10.1002/mco2.70242}
}RIS
TY - JOUR TI - The Arming of Natural Killer Cells With Fc‐Engineered Monoclonal Antibodies Confers Specificity Against Tumor B Cells AU - Michaël Constantinides AU - Loïs Coënon AU - Paolo Falvo AU - Caroline Multrier AU - Davide Lombardi AU - Francesco Bertolini AU - Pierre Martineau AU - Bruno Robert AU - Guillaume Cartron AU - Martin Villalba PY - 2025 JO - MedComm DO - 10.1002/mco2.70242 UR - https://doi.org/10.1002/mco2.70242 ER -
APA
Constantinides, M., Coënon, L., Falvo, P., Multrier, C., Lombardi, D., Bertolini, F., Martineau, P., Robert, B., Cartron, G., & Villalba, M. (2025). The Arming of Natural Killer Cells With Fc‐Engineered Monoclonal Antibodies Confers Specificity Against Tumor B Cells. MedComm. https://doi.org/10.1002/mco2.70242
Source records
- crossref · retrieved 2026-09-25T06:06:27.351Z